Clinical Trials Browser

Phase 2 × Amyloidosis × pomalidomide × Clear all

NCT05066607 2024-03-06

IsAMYP

Phase 2 Unknown

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT03959358 2023-07-24

A Study to Desensitize Allergic Reactions to Treatments for Blood Disorders

Phase 2 Completed

Amyloidosis, Multiple Myeloma